-
PAS IV, an integral membrane protein of mammary epithelial cells, is related to platelet and endothelial cell CD36 (GP IV).
Department of Chemistry, San Jose State University, California 95192-0101.
PAS IV is a 78-kDa (bovine) to 80-kDa (human) integral membrane glycoprotein of unknown function which is found in mammary epithelial cells. We now report the purification of human PAS IV and native bovine PAS IV from the milk fat globule membrane (MFGM), a preparation of apical plasmalemma from epithelial cells of lactating mammary tissue. N-Terminal sequence analyses of human and bovine PAS IV revealed homology to the N-terminal sequence of the 88-kDa human endothelial and platelet glycoprotein CD36. The similarity of MFGM PAS IV to platelet CD36 was further established by immunoblots of purified platelet CD36 and MFGM PAS IV with MFGM PAS IV specific antiserum. The removal of N-linked oligosaccharides from PAS IV and CD36 by treatment with endoglycosidase F reduced the apparent Mr of both proteins to approximately 57,000. These data suggest that PAS IV and CD36 are similar if not identical polypeptides that undergo cell type specific glycosylation.
PMID: 1699598 [PubMed - indexed for MEDLINE]
-
Cited by 8 PubMed Central articles
-
CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine.
Nauli AM, Nassir F, Zheng S, Yang Q, Lo CM, Vonlehmden SB, Lee D, Jandacek RJ, Abumrad NA, Tso P.
Gastroenterology. 2006 Oct; 131(4):1197-207. Epub 2006 Aug 16.
[Gastroenterology. 2006]
-
The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein.
Malaud E, Hourton D, Giroux LM, Ninio E, Buckland R, McGregor JL.
Biochem J. 2002 Jun 1; 364(Pt 2):507-15.
[Biochem J. 2002]
-
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.
Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL.
J Clin Invest. 2000 Apr; 105(8):1049-56.
[J Clin Invest. 2000]
- » See all...